Cancer BiologybioRxiv
Evidence of Increased Hemangioblastic and Early Hematopoietic Potential in Chronic Myeloid Leukemia (CML)-derived Induced Pluripotent Stem Cells (iPSC)
G. Telliam, O. Feraud, S. Baykal…·A. TURHAN
This study shows that CML-derived iPSC have expanded hemangioblast and hematopoietic progenitor potential compared to H1-ESC, with AHR signaling as a potential therapeutic target.